Lars Østergaard
Researcher Next ID · RN-038951
Researcher · Immunology and Microbiology
Aarhus, Denmark
- Works count
- 450
- Citation count
- 16,475
- H-index
- 64
- i10-index
- 257
Research interests
Publications
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30555-6
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
PLoS Pathogens · 2015 · https://doi.org/10.1371/journal.ppat.1005142
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
The Lancet HIV · 2014 · https://doi.org/10.1016/s2352-3018(14)70014-1
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
Proceedings of the National Academy of Sciences · 2013 · https://doi.org/10.1073/pnas.1311669110
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Journal of Autism and Developmental Disorders · 2010 · https://doi.org/10.1007/s10803-010-1006-y
Current projects
No projects listed.